阿奇拉粉的物理化学,热学和消化特性经过单一和双重化学修改而得到修改
Vicente Espinosa-Solis1, Cesar Roldan-Cruz2, Walfred Rosas-Flores3
1Coordinación Académica Región Huasteca Sur, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Journal of food science
|April 10, 2025
概括
使用酸水解和酸对阿奇拉粉进行双重化学修饰,显著提高了其耐性粉含量和热稳定性. 这些改性粉显示出各种食品应用的前景.
科学领域:
- 食品科学与技术 食品科学与技术
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 阿奇拉粉 (NS) 具有独特的特性,但需要对更广泛的食品应用进行修改.
- 化学改造是为满足特定工业需求而定制粉功能的一个关键策略.
- 了解不同修饰方法对粉性质的影响对于产品开发至关重要.
研究的目的:
- 研究单一和双重化学修饰对阿奇拉粉 (NS) 的影响.
- 分析对物理化学,热学,学和消化性能的影响.
- 探索食品产品中增强应用的潜力.
主要方法:
- 单次修改:轻度酸水解 (0.1M HCl) 6小时和12小时.
- 双重修饰:酸性水解,然后用酸化物或酸 (CA) 进行化.
- 使用富里埃变换红外,X射线衍射,热分析,质学和消化性测试进行了表征.
主要成果:
- 与单个修改相比,双重修改显著改变了阿奇拉粉的结构组织.
- 改性粉呈现了减少的质量损失,增加的水溶性和减少的膨胀力.
- 峰值粘度显著下降,归因于水解和基组的加入.
- 与CA的双重修饰显著增加了耐性粉含量 (从13.91%增加到79.80%),同时减少了快速消化的粉.
结论:
- 双重化学修饰,特别是酸化,产生具有高耐性粉含量的功能化阿奇拉粉.
- 这些改性粉具有增强的热稳定性,使其适用于热加工和冷食品.
- 由于双重修饰而产生的明显变化,扩大了阿奇拉粉在汁,,冷和乳制品中的应用潜力.
相关概念视频
Factors Influencing Drug Absorption: Physicochemical Parameters
189
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
189
Factors Influencing Drug Absorption: Pharmaceutical Parameters
104
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
104
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
486
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
486
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
158
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
158
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Physical and Chemical Properties of Matter
142.2K
The characteristics that enable us to distinguish one substance from another are called properties.
142.2K


